Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Go back to Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
(NASDAQ: KYNB) Delayed: 7.13 +0.37 (5.47%)
Previous Close $6.76    52 Week High
Open $6.80    52 Week Low
Day High $7.95    P/E N/A 
Day Low $6.72    EPS
Volume 461,343